{"data_non_statistical":false,"goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0b-01.pdf","goal_meta_link_text":"United Nations Sustainable Development Goals Metadata (PDF 4.0 MB)","graph_title":"Proportion of the target population covered by all vaccines included in their national programme","graph_type":"line","indicator_number":"3.b.1","indicator_name":"Proportion of the target population covered by all vaccines included in their national programme","indicator_sort_order":"03-bb-01","published":true,"reporting_status":"complete","sdg_goal":"3","target_name":"Support the research and development of vaccines and medicines for the communicable and non\u2010communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","target_id":"3.b","un_custodian_agency":"World Health Organization (WHO), United Nations Children\u2019s Fund (UNICEF)","un_designated_tier":"3","source_organisation_1":"UNSTATS","source_url_1":"https://unstats.un.org/sdgs/indicators/database/","source_active_1":true,"graph_titles":[{"series":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)","title":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"series":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)","title":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"series":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)","title":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)"}],"composite_breakdown_label":"Name of non-communicable disease","page_content":"","national_metadata_update_url_text":"2023-10-26: see changes on GitHub","national_metadata_update_url":"https://github.com/sdgbih/sdg-data-bosnia/commit/0297e9c39e38b462dc5d15e61b075bfcc15c5841","national_data_update_url_text":"2023-10-26: see changes on GitHub","national_data_update_url":"https://github.com/sdgbih/sdg-data-bosnia/commit/0297e9c39e38b462dc5d15e61b075bfcc15c5841","indicator":"3.b.1"}